Daniel Sallmon

  • Citations Per Year
Learn More
BACKGROUND Long-term survival (LTS) in patients (pts) with pancreatic cancer is still uncommon, little data is available to identify long-term survivors. The CONKO-001 study, which established gemcitabine after resection as adjuvant therapy, may provide data to answer this question. METHODS CONKO-001 pts with an overall survival ≥5 years were compared to(More)
  • 1